apoptosis, 9 microvesicle formation, 10 nucleocytoplasmic transport, 11 epigenetic silencing 12 and embryonic development. 13, 14 CSE1L also functionally interacts with P53 and associates with a panel of P53 target gene promoters to determine cellular outcome. 15 The CSE1L gene maps to 20q13, a chromosome region correlated with the development of solid tumours. 16 CSE1L is highly expressed in various types of cancers, such as ovarian tumours, 17 hepatocellular carcinoma (HCC), 7 lymphomas, 18 colorectal tumours, 19 breast tumours, 8 melanomas, 20 bladder cancer, 21 lung cancer, 22 oligodendroglial tumours 23 and thyroid tumours, 24 and CSE1L expression is correlated with cancer grade, cancer stage and poor cancer outcome. 25 However, the regulatory mechanism of the CSE1L signalling pathway on cancer progression is still obscure; only a few studies have reported on the interaction of CSE1L with other cancer signalling pathways. In ovarian cancer cell lines, CSE1L regulates the expression of the pro-apoptotic genes RASSF1C and RASSF1A to protect tumour cells from death. 26 Another study suggested that AKT activation forces the nuclear accumulation of CSE1L in the ovarian cancer cell, likely to induce pro-oncogenic signals. 17 Winkler et al 27 demonstrated that CSE1L and its transport substrate importin-α1 (imp-α1) are highly expressed in HCC and maintain HCC cell survival by regulating the X-linked inhibitor of apoptosis. In melanogenesis, CSE1L links and regulates cAMP/PKA and Ras/ERK signal pathways to induce CREB and MITF expression. 28 In another study, the CSE1L protein was found to interact with mutS homolog 6 (MSH6) and positively regulate the MSH6 protein to promote osteosarcoma progression. 29 CSE1L, also as a microvesicle membrane protein, can be detected in tumour-derived exosomes/microvesicles. 10 Because tumour cells secrete exosomes/microvesicles more frequently than do normal cells, CSE1L can be used as a diagnostic marker for tumours. 30 Despite all these functions of CSE1L reported in multiple types of cancers, the clinical significance of CSE1L in testicular cancer has not been demonstrated. Herein, we found that the CSE1L protein is enriched in human seminoma tissue samples. We further knocked down CSE1L in a seminoma cell line TCam-2 to investigate CSE1L function in testicular cancers. We also utilized immunofluorescence images to show how CSE1L is associated with mitotic spindles during the TCam-2 cell cycle and may facilitate seminoma cell division.
| MATERIAL S AND ME THODS

| Human tissue and cell culture
The study protocol was approved by the Ethics Committee of the Human testis and seminoma tissue from four patients were obtained from the Xiangyang Central Hospital and The First People'
Hospital of Tianmen City and fixed in Bouin's solution (Sigma, Munich, Germany). The samples were then embedded in a solid block of paraffin wax for use in permanent slides.
TCam-2 cells were cultured in high-glucose DMEM media (Gibco, USA) supplemented with 10% foetal bovine serum (FBS; Gibco, Grand Island, NY, USA) at 37°C and 5% CO 2 incubation.
| Immunohistochemistry and immunocytochemistry
The seminoma tissues embedded in paraffin were sectioned to 4 μm slices and mounted to slides. Slides were gradient dewaxed, rehydrated and processed for heat-activated antigen retrieval by using a microwave for 10 minutes. Then, the slides were cooled to room temperature. For immunofluorescence, the slides were blocked and then incubated with rabbit anti-CSE1L antibody ( 
| IHC data analysis
Average staining of CSE1L protein in seminoma tissue and non-tumoral normal testis tissue was quantified by colour deconvolution of IHC micrographs using the IHC profiler plugin integrated into the ImageJ software. 31 Five fields per IHC slide were calculated, and the most frequent score was selected as the score result of this slide; IHC score: 3+ (highly positive); 2+ (positive); 1+ (low-positive); 0 (negative). Eight slides of IHC experiments were performed on each tissue sample and quantified by the above method. During the evaluation, IHC slides were blind-coded.
| RNA interference (RNAI)
Pre-designed siRNA sequences targeted to human CSE1L (KD1: 5ʹ-GCATGATCCTGTAGGTCAA-3ʹ; KD2: 5ʹ-GCATGGAATTACACAAGCA 
CSE1L-R 5ʹ-TTGTGAAGTGACTGTGCC-3ʹ, GAPDH-F 5ʹ-GTCAGCCGC
ATCTTCTTTTG-3ʹ and GAPDH-R 5ʹ-GCGCCCAATACGACCAAATC-3ʹ.
| Protein extraction
Cells were lysed with RIPA lysis buffer (Beyotime, Shanghai, China)
supplemented with proteinase inhibitors (Sigma). After centrifugation with 14 000 g for 10 minutea at 4°C, the supernatant was collected. The protein concentration of the supernatant was evaluated using a BCA Protein Assay Kit (Pierce, Bonn, Germany). Then, the supernatant was added with SDS loading buffer and boiled at 100°C for 7 minutes. Afterwards, protein samples were stored at −80°C for immunoblotting.
| Immunoblotting
Protein samples were loaded onto an 8% separation gel and 5%
spacer gel, and the gels were transferred to PVDF membranes 
| Cell proliferation experiment
| Cell cycle assay
TCam-2 cells cultured in six-well plates were transfected with siRNAs at 30%-50% confluence and then cultured for 48 hours in 37°C with 5% CO 2 and DMEM supplemented with 10% FBS. Then, the cells were digested with 0.25% trypsin (Gibco) and fixed in 50% ethanol at −20°C
overnight. The cells were incubated with RNase A (Fermentas, Hanover, MD, USA) at 37°C water bath for 30 minutes, stained with 50 μg/mL propidium iodide (Kaiji, Nanjing, China), and then 2 × 10 4 cells were analysed using a FACSort flow cytometer (BD Biosciences, San Jose, CA, USA). The results were examined using the ModFit LT software (BD Biosciences). Assays were independently performed three times.
| Bromodeoxyuridine (BrdU) incorporation assay
TCam-2 cells were seeded onto coverslips in 12-well culture plates and transfected with negative control siRNA and CSE1L-siRNA at 30%-50%
confluence. After transfection, the cells were cultured with DMEM supplemented with 10% FBS for 24 hours. The cells were starved in serumfree DMEM for 16 hours, and 30 μg/mL of BrdU (Abcam) was added to the medium. After 18 hours of culture, the cell slides were fixed with 4% PFA for 15 minutes and washed three times with PBS. The immunocytochemical staining was performed using rat anti-BrdU antibody 
| Statistical analysis
All quantitative data represent the means and SD of at least three independent experiments. Statistical analyses between different groups were performed using a one-way ANOVA (**P < 0.01 and *P < 0.05).
| RE SULTS
| CSE1L is significantly enriched in human seminoma tissues
CSE1L is significantly overexpressed in multiple types of tumours in comparison with their corresponding normal tissues, such as the colorectum, liver, breast, thyroid and ovary. 18, 19, 24, [32] [33] [34] However, whether CSE1L plays a role in seminomas is unclear. To help diagnose the type of testicular cancers, we first performed HE staining on the seminoma tissues and the corresponding non-tumour normal tissues from testicular cancer patients ( Figure 1A ). In the proliferation. Overall, we presumed that CSE1L may be highly involved in cell division of seminomas.
| Localization of CSE1L during the cell cycle
To explore how CSE1L functions in seminoma cancers, we used the seminoma TCam-2 cells to determine the location of endogenous CSE1L during cell division by immunofluorescence. In the interphase, CSE1L was mainly distributed in the nucleus, whereas α-tubulin was located in the cytoplasm ( Figure 3A) . However, in the prophase, 
| Loss of function of CSE1L affects cell proliferation and cell cycle
Because CSE1L was demonstrated to be associated with the spindle and centrosome in TCam-2 cells, we opted to interfere with the 
| CSE1L defects in TCam-2 cells disrupt cell mitosis
In a previous study, we found that CSE1L co-localized with spindle and centrosomes during TCam-2 cell division, and CSE1L deficiency induced cell cycle arrest in the G2/M phase; thus, we speculated that CSE1L may disrupt the progression of cell division. To confirm our hypothesis, we performed immunostainings Figure 5B , many mitotic cells showed more than two centrosomes. Statistical data revealed that after CSE1L knockdown, the ratio of centrosome number to dividing cell number was higher than that of the normal dividing cells containing two centrosomes ( Figure 5D ). Overall, these data demonstrated that CSE1L can facilitate the completion of normal cell mitosis in TCam-2 cells.
| D ISCUSS I ON
The high expression of CSE1L in various types of tumours was reported in many studies. However, no study is available concerning CSE1L expression in TGCTs. Herein, we found that CSE1L was sig- by RNAi in primary papillary thyroid carcinoma cell line B-CPAP led to reduced cell proliferation; this phenotype was confirmed by the significantly reduced BrdU incorporation in CSE1L knockdown groups. 24 To investigate the functional significance of CSE1L in osteosarcoma, authors performed the RNAi of CSE1L in the two osteosarcoma cell lines MNNG/HOS and U2OS, and cell growth was significantly inhibited. Cell cycle assay showed a delayed G1 phase transition. 29 In our study, the cell ratio was increased in the G0/G1
phase and decreased in the S phase in CSE1L-deficient TCam-2 cells.
The BrdU incorporation in the CSE1L-KD1 and CSE1L-KD2 groups was significantly reduced relative to those in the control groups.
Because BrdU is a marker of S phase cells, the above-mentioned data partly explained the inhibited cell proliferation, which was caused by the delay of cell cycle progression by G1 phase transition suppression.
In our study, we found that the CSE1L protein was clearly co- 
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KIFC3 and KIF3b, members of the human kinesin family, have been reported to be highly expressed in seminoma tissues; the proteins also bind along the spindle and affect spindle formation in Hela cells. 40, 41 Given these data, we conclude that CSE1L is essential to
proper cell division and the disrupted CSE1L expression in TCam-2 cells led to M phase delay.
Centrosomes play an important role in orderly chromosome segregation by contributing to bipolar spindle formation during cell mitosis. 42 The mitotic spindle of a normal cell possesses two poles, each containing a single centrosome. 43 However, most cancer cells harbour redundant centrosomes through the process termed centrosome amplification. 44 This characteristic is expected to cause cells to form multipole spindles and disrupt cell mitosis. 45 Cancer cells settle this problem by clustering extra centrosomes into two poles to form a pseudo-bipolar spindle. 46 Several proteins distributed in the centrosome have been shown to be involved in regulating centrosomal gathering. 47, 48 In the TCam-2 cells, the CSE1L protein co-localizes with the centrosomal marker γ-tubulin;
thus, we presume that CSE1L is engaged in centrosomal clustering in cancer cells. However, this assumption requires accurate experiments for verification. 
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